An EGSnrc Monte Carlo-calculated database of TG-43 parameters

Medical Physics

Volumn 35, Issue 9, 2008, Pages 4228-4241

  Taylor, R E P ^a   Rogers, D W O ^a  

^a CARLETON UNIVERSITY   (Canada)

Author keywords

Anisotropy function; Database; Dose rate constant; EGSnrc; I 125; LDR brachytherapy; Monte Carlo; Pd 103; Radial dose function

Indexed keywords

ANISOTROPY; DATABASE SYSTEMS; DOSIMETRY; ONCOLOGY; PHOTONS; RADIOTHERAPY; RATE CONSTANTS; WEBSITES;

DOSE RATE CONSTANTS; EGSNRC; LDR BRACHYTHERAPY; MONTE CARLO CALCULATION; PUBLICLY ACCESSIBLE; RADIAL DOSE FUNCTION; RADIOTHERAPY PHYSICS; SPATIAL RESOLUTION;

MONTE CARLO METHODS;

IODINE 125; PALLADIUM 103;

ANISOTROPY; ARTICLE; BRACHYTHERAPY; CALCULATION; DOSIMETRY; GEOMETRY; MONTE CARLO METHOD; PHOTON; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION;

EID: 50449095484     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.2965360     Document Type: Article

References (85)

1. Radiological Physics Center, The joint AAPM/RPC registry of brachytherapy sources., The M.D. Anderson Cancer Center, Houston, Texas; see http://rpc.mdanderson.org/rpc/.
2. R. Nath, L. L. Anderson, G. Luxton, K. A. Weaver, J. F. Williamson, and A. S. Meigooni, " Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43.," Med. Phys. 22, 209-234 (1995).
3. M. J. Rivard, B. M. Coursey, L. A. DeWerd, M. S. Huq, G. S. Ibbott, M. G. Mitch, R. Nath, and J. F. Williamson, " Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.," Med. Phys. 31, 633-674 (2004).
4. M. J. Rivard, W. M. Butler, L. A. DeWerd, M. S. Huq, G. S. Ibbott, A. S. Meigooni, C. S. Melhus, M. G. Mitch, R. Nath, and J. F. Williamson, " Supplement to the 2004 update of the AAPM Task Group No. 43 Report.," Med. Phys. 34, 2187-2205 (2007).
5. J. F. Williamson, " Comparison of measured and calculated dose rates in water near I-125 and Ir-192 seeds.," Med. Phys. 18, 776-786 (1991).
6. J. F. Williamson, " Monte Carlo evaluation of kerma at a point for photon transport problems.," Med. Phys. 14, 567-576 (1987).
7. MCNP-A general Monte Carlo N-particle Transport Code Version 5, Report LA-UR-03-1987, edited by, F. B. Brown, (Los Alamos National Laboratory, Los Alamos, NM, 2003).
8. I. Kawrakow, " Accurate condensed history Monte Carlo simulation of electron transport. I. EGSnrc, the new EGS4 version.," Med. Phys. 27, 485-498 (2000).
9. I. Kawrakow and D. W. O. Rogers, The EGSnrc Code System: Monte Carlo simulation of Electron and Photon Transport, Technical Report PIRS-701 (National Research Council of Canada, Ottawa, Canada, 2000).
10. G. Yegin and D. W. O. Rogers, " A fast Monte Carlo code for multi-seed brachytherapy treatments including interseed effects.," Med. Phys. 31, 1771 (abs) (2004).
11. G. Yegin, R. E. P. Taylor, and D. W. O. Rogers, " BrachyDose: An EGSnrc user-code for full Monte Carlo simulation of brachytherapy implants using CT data.," unpublished.
12. R. E. P. Taylor, G. Yegin, and D. W. O. Rogers, " Benchmarking BrachyDose: Voxel-based EGSnrc Monte Carlo calculations of TG-43 dosimetry parameters.," Med. Phys. 34, 445-457 (2007).
13. G. Yegin, " A new approach to geometry modelling of Monte Carlo particle transport: an application to EGS.," Nucl. Instrum. Methods Phys. Res. B 211, 331-338 (2003).
14. M. J. Berger and J. H. Hubbell, XCOM: Photon Cross Sections on a Personal Computer., Report NBSIR87-3597, NIST, Gaithersburg, MD 20899, 1987.
15. J. F. Williamson and M. J. Rivard, " Quantitative dosimetry methods for brachytherapy.," in Brachytherapy Physics, edited by, B. R. Thomadsen, M. J. Rivard, and, W. M. Butler, (Medical Physics, Madison, WI, 2005), pp. 233-294.
16. I. Kawrakow, " On the effective point of measurement in megavoltage photon beams.," Med. Phys. 33, 1829-1839 (2006).
17. J. F. Williamson, " Monte Carlo modeling of the transverse-axis dose distribution of the Model 200 Pd103 interstitial brachytherapy source.," Med. Phys. 27, 643-654 (2000).
18. A. S. Kirov and J. F. Williamson, " Monte Carlo-aided dosimetry of the Source Tech Medical model STM1251 I-125 interstitial brachytherapy source.," Med. Phys. 28, 764-772 (2001).
19. J. I. Monroe and J. F. Williamson, " Monte Carlo-aided dosimetry of the Theragenics TheraSeed model 200 Pd103 interstitial brachytherapy seed.," Med. Phys. 29, 609-621 (2002).
20. G. Lymperopoulou, P. Papagiannis, A. Angelopoulos, L. Sakelliou, P. Karaiskos, P. Sandilos, A. Przykutta, and D. Baltas, " Monte Carlo and thermoluminescence dosimetry of the new IsoSeed model I125.S17 I125 interstitial brachytherapy seed.," Med. Phys. 32, 3313-3317 (2005).
21. R. Loevinger, " Wide-angle free-air chamber for calibration of low-energy brachytherapy sources.," Med. Phys. 20, 907 (1993).
22. S. M. Seltzer, P. J. Lamperti, R. Loevinger, M. G. Mitch, J. T. Weaver, and B. M. Coursey, " New national air-kerma-strength standards for I125 and Pd103 brachytherapy Seeds.," J. Res. Natl. Inst. Stand. Technol. 108, 337-358 (2003).
23. J. Dolan, Z. Li, and J. F. Williamson, " Monte Carlo and experimental dosimetry of an I125 brachytherapy seed.," Med. Phys. 33, 4675-4684 (2006).
24. J. F. Williamson and F. J. Quintero, " Theoretical evaluation of dose distributions in water models 6711 and 6702 I125 seeds.," Med. Phys. 15, 891-897 (1988).
25. J. F. Williamson, " Monte Carlo evaluation of specific dose constants in water for I125 seeds.," Med. Phys. 15, 686-694 (1988).
26. E. Mainegra, R. Capote, and E. Lopez, " Dose rate constants for Pd103, I125, Yb196, Ir192, brachytherapy sources: An EGS4 Monte Carlo study.," Phys. Med. Biol. 43, 1557-1566 (1998).
27. E. Mainegra, R. Capote, and E. Lopez, " Radial dose functions for Pd103, I125, Yb196, Ir192, brachytherapy sources: An EGS4 Monte Carlo study.," Phys. Med. Biol. 45, 703-717 (2000).
28. R. Capote, E. Mainegra, and E. Lopez, " Anisotropy functions for low energy interstitial brachytherapy sources: An EGS4 Monte Carlo study.," Phys. Med. Biol. 46, 135-150 (2001).
29. K. Sowards and A. S. Meigooni, " A Monte Carlo evaluation of the dosimetric characteristics of the EchoSeedTM model 6733 I125 brachytherapy source.," Brachytherapy 1, 227-232 (2002).
30. A. S. Meigooni, S. A. Dini, K. Sowards, J. L. Hayes, and A. Al-Otoom, " Experimental determination of the TG-43 dosimetric characteristics of EchoSeed model 6733 I125 brachytherapy source.," Med. Phys. 29, 939-942 (2002).
31. R. Pirchio, E. Galiano, M. Saravi, D. Banchik, and C. Muñoz, " On the physical, spectra, and dosimetric characteristics of a new I125 brachytherapy source.," Med. Phys. 34, 2801-2806 (2007).
32. H. Hedtjärn, G. A. Carlsson, and J. F. Williamson, " Monte Carlo-aided dosimetry of the symmetra model I25.S06 I125, interstitial brachytherapy seed.," Med. Phys. 27, 1076-1085 (2000).
33. N. S. Patel, S.-T. Chiu-Tsao, J. F. Williamson, P. Fan, T. Duckworth, D. Shasha, and L. B. Harrison, " Thermoluminescent dosimetry of the Symmetra I125 model I25.S06 interstitial brachytherapy seed.," Med. Phys. 28, 1761-1769 (2001).
34. E. Pantelis, D. Baltas, E. Georgiou, P. Karaiskos, G. Lymperopoulou, P. Papariannis, L. Sakelliou, I. Seimenis, and E. Stilliaris, " Dose characterization of the new Bebig IsoSeed I25.S17 using polymer gel and MRI.," Nucl. Instrum. Methods Phys. Res. A 569, 529-532 (2006).
35. K. Sowards and A. S. Meigooni, " A Monte Carlo evaluation of the dosimetric characteristics of the Best model 2301 I125 brachytherapy source.," Brachytherapy 57, 327-333 (2002).
36. A. S. Meigooni, D. M. Gearheart, and K. Sowards, " Experimental determination of dosimetric characteristics of Best I125 brachytherapy source.," Med. Phys. 27, 2168-2173 (2000).
37. R. Nath and N. Yue, " Dosimetric characterization of an encapsulated interstitial brachytherapy source of I125 on a tungsten substrate.," Brachytherapy 1, 102-109 (2002).
38. J. F. Williamson, " Dosimetric characteristics of the DRAXIMAGE model LS-1 interstitial brachytherapy source design: A Monte Carlo investigation.," Med. Phys. 29, 509-521 (2002).
39. R. Wang and R. Sloboda, " Monte Carlo dose parameters of the BrachySeed model LS-1 I125 brachytherapy source.," Appl. Radiat. Isot. 56, 805-813 (2002).
40. G. Chan and W. V. Prestwich, " Dosimetric properties of the new I125 BrachySeed model LS-1 source.," Med. Phys. 29, 190-200 (2002).
41. G. H. Chan, R. Nath, and J. F. Williamson, " On the development of consensus values of reference dosimetry parameters for interstitial brachytherapy sources.," Med. Phys. 31, 1040-1045 (2004).
42. R. Nath and N. Yue, " Experimental determination of a newly designed encapsulated interstitial brachytherapy source of iodine-125-model LS-1 BrachySeed.," Appl. Radiat. Isot. 55, 813-821 (2001).
43. A. S. Meigooni, M. M. Yoe-Sein, A. Y. Al-Otoom, and K. Sowards, " Determination of the dosimetric characteristics of InterSource I125 brachytherapy source.," Appl. Radiat. Isot. 56, 589-599 (2002).
44. B. Reniers, S. Vynckier, and P. Scalliet, " Dosimetric study of the new InterSource125 iodine seed.," Med. Phys. 28, 2285-2299 (2001).
45. M. J. Rivard, W. M. Butler, L. A. DeWerd, M. S. Huq, G. S. Ibbott, C. S. Melhus, M. G. Mitch, R. Nath, and J. J. Williamson, " Response to "Comment on 'Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.," Med. Phys. 32, 1822-1824 (2005).
46. D. M. Gearheart, A. Drogin, K. Sowards, A. Meigooni, and G. S. Ibbott, " Dosimetric characteristics of a new I125 brachytherapy source.," Med. Phys. 27, 2278-2285 (2000).
47. R. Nath and N. Yue, " Dose distribution along the transverse axis of a new I125 source for interstitial brachytherapy.," Med. Phys. 27, 2536-2540 (2000).
48. G. S. Ibbott and R. Nath, " Dose-rate constant for Imagyn I125 brachytherapy source.," Med. Phys. 28, 705 (2001).
49. G. S. Ibbott, " Monte Carlo determination of dose rate constant.," Med. Phys. 29, 1637-1638 (2002).
50. M. J. Rivard, " Comprehensive Monte Carlo calculations of AAPM Task Group Report No. 43 dosimetry parameters for the model 3500 I-Plant I125 brachytherapy source.," Appl. Radiat. Isot. 57, 381-389 (2002).
51. D. Duggan and B. L. Johnson, " Improved radial dose function estimation using current version MCNP Monte Carlo simulation: Model 6711 and ISC3500 125I brachytherapy sources.," Appl. Radiat. Isot. 61, 1443-1450 (2004).
52. D. Duggan and B. L. Johnson, " Dosimetry of the I-Plant model 3500 iodine-125 brachytherapy source.," Med. Phys. 28, 661-670 (2001).
53. R. E. Wallace, " Model 3500 I125 brachytherapy source dosimetric characterization.," Appl. Radiat. Isot. 56, 581-587 (2001).
54. A. S. Meigooni, J. L. Hayes, H. Zhang, and K. Sowards, " Experimental and theoretical determination of dosimetric characteristics of IsoAid ADVANTAGETM I125 brachytherapy source.," Med. Phys. 29, 2152-2158 (2002).
55. T. D. Solberg, J. J. DeMarco, G. Hugo, and R. E. Wallace, " Dosimetric parameters of three new solid core I-125 brachytherapy sources.," J. Appl. Clin. Med. Phys. 3, 119-134 (2002).
56. Z. Li, " Monte Carlo calculations of dosimetry parameters of the Urocor Prostaseed I125 source.," Med. Phys. 29, 1029-1034 (2002).
57. R. E. Wallace, " Empirical dosimetric characterization of model I125-SL Iodine125 brachytherapy source in phantom.," Med. Phys. 27, 2796-2802 (2000).
58. M. J. Rivard, " Monte Carlo calculations of AAPM Task Group Report No. 43 dosimetry parameters for the MED3631-A/M I125 source.," Med. Phys. 28, 629-637 (2001).
59. Z. Li, J. J. Fan, and J. R. Palta, " Experimental measurements of dosimetric parameters on the transverse axis of a new I125 source.," Med. Phys. 27, 1275-1280 (2000).
60. R. E. Wallace and J. J. Fan, " Report on the dosimetry of a new design Iodine125 brachytherapy source.," Med. Phys. 26, 1925-1931 (1999).
61. P. Karaiskos, P. Papagiannis, L. Sakelliou, G. Anagnostopoulos, and D. Baltas, " Monte Carlo dosimetry of the selectSeed I125 interstitial brachytherapy seed.," Med. Phys. 28, 1753-1760 (2001).
62. G. Anagnostopoulos, D. Baltas, P. Karaiskos, P. Sandilos, P. Papagiannis, and L. Sakelliou, " Thermoluminescent dosimetry of the selectSeed I125 interstitial brachytherapy seed.," Med. Phys. 29, 709-716 (2002).
63. P. Papagiannis, L. Sakelliou, G. Anagnostopoulos, and D. Baltas, " On the dose rate constant of the selectSeed I125 interstitial brachytherapy seed.," Med. Phys. 33, 1522-1523 (2006).
64. S. Chiu-Tsao, T. L. Duckworth, C. Hsiung, Z. Li, J. Williamson, N. Patel, and L. B. Harrison, " Thermoluminescent dosimetry of the SourceTech Medical model STM1251 I125 seed.," Med. Phys. 30, 1735-1732 (2003).
65. Z. Li and J. F. Williamson, " Measured transverse-axis dosimetric parameters of the model STM1251 I125 interstitial source.," J. Appl. Clin. Med. Phys. 3, 212-217 (2002).
66. C. C. Popescu, J. Wise, K. Sowards, A. S. Meigooni, and G. S. Ibbott, " Dosimetric characteristics of the PharmaSeed model BT-125-1 source.," Med. Phys. 27, 2174-2181 (2000).
67. J. J. DeMarco, G. Hugo, and T. D. Solberg, " Dosimetric characteristics for three low-energy brachytherapy sources using the Monte Carlo N-Particle code.," Med. Phys. 29, 662-668 (2002).
68. G. M. Daskalov and J. F. Williamson, " Monte Carlo-aided dosimetry of the new Bebig IsoSeed Pd103 interstitial brachytherapy seed.," Med. Phys. 28, 2154-2161 (2001).
69. A. S. Meigooni, Z. Bharucha, M. Yoe-Sein, and K. Sowards, " Dosimetric characteristics of the Best double-wall Pd103 brachytherapy source.," Med. Phys. 28, 2567-2575 (2001).
70. S. W. Peterson and B. Thomadsen, " Measurements of the dosimetric constants for a new Pd103 brachytherapy source.," Brachytherapy 1, 110-119 (2002).
71. A. S. Meigooni, H. Zhang, C. Perry, S. A. Dini, and R. A. Koona, " Theoretical and experimental determination of dosimetric characteristics for brachyseed Pd-103, model Pd-1, source.," Appl. Radiat. Isot. 58, 533-541 (2003).
72. R. Nath, N. Yue, and E. Roa, " Experimental determination of dosimetric characterization of a newly designed encapsulated interstitial brachytherapy source of Pd103 -model Pd-1.," Med. Phys. 29, 2433-2434 (2002).
73. G. Chan and W. V. Prestwich, " Monte Carlo investigation of the dosimetric properties of the new Pd103 BrachySeed model Pd-1 source.," Med. Phys. 29, 1984-1990 (2002).
74. A. S. Meigooni, K. Sowards, and M. Soldano, " Dosimetric characteristics of InterSource103 palladium brachytherapy source.," Med. Phys. 27, 1093-1100 (2000).
75. S. Bernard and S. Vynckier, " Dosimetric study of a new polymer encapsulated Pd103 seed.," Phys. Med. Biol. 50, 1493-1504 (2005).
76. Z. Wang and N. Hertel, " Determination of dosimetric characteristics of OptiSeed a plastic brachytherapy Pd103 source.," Appl. Radiat. Isot. 63, 311-321 (2005).
77. A. S. Meigooni, S. Dini, K. Dou, S. Awan, and G. Gopalakrishnan, " Experimental and Monte Carlo dosimetric characterization of ADVANTAGE Pd103.," Appl. Radiat. Isot. 64, 881-887 (2006).
78. K. Sowards, " Monte Carlo dosimetric characterization of the IsoAid ADVANTAGE Pd103 brachytherapy source.," J. Appl. Clin. Med. Phys. 8, 18-25 (2007).
79. M. J. Rivard, " A discretized approach to determining TG-43 brachytherapy dosimetry parameters: Case study using Monte Carlo calculations for the MED3633 Pd103 source.," Appl. Radiat. Isot. 55, 775-782 (2001).
80. Z. Li, J. R. Palta, and J. J. Fan, " Monte Carlo caculations and experimental measurements of dosimetry parameters of a new Pd103 source.," Med. Phys. 27, 1108-1112 (2000).
81. Z. Chen and R. Nath, " Dose rate constant and energy spectrum of interstitial brachytherapy sources.," Med. Phys. 28, 86-96 (2001).
82. R. E. P. Taylor and D. W. O. Rogers, " More accurate fitting of I125 and Pd103 radial dose functions.," Med. Phys. 35, 4242-4250 (2008).
83. R. E. P. Taylor and D. W. O. Rogers, " The Carleton Laboratory for Radiotherapy Physics TG-43 Parameter Database.," http://www.physics. carleton.ca/clrp/seed_database/.
84. R. E. Wallace and J. J. Fan, " Dosimteric characterization of a new design Pd103 brachytherapy source.," Med. Phys. 26, 2465-2470 (1999).
85. R. Nath, N. Yue, K. Shahnazi, and P. Bongiorini, " Measurement of dose-rate constant for Pd103 seeds with air kerma strength calibration based upon a primary national standard.," Med. Phys. 27, 655-658 (2000).